PARP1 and cancer: Mechanistically, the high level of ROS in cancer promotes the activation and translocation of cMET into the nucleus where it directly binds and phosphorylates the tyrosine residue 907 (Y907) of PARP1 to enhance its enzymatic activity (Figure 4A) [128,130,131].